...
首页> 外文期刊>Therapeutic advances in musculoskeletal disease. >Body composition in patients with rheumatoid arthritis: a narrative literature review
【24h】

Body composition in patients with rheumatoid arthritis: a narrative literature review

机译:类风湿性关节炎患者的身体组成:叙事文献综述

获取原文

摘要

There is growing interest in the alterations in body composition (BC) that accompany rheumatoid arthritis (RA). The purpose of this review is to (i) investigate how BC is currently measured in RA patients, (ii) describe alterations in body composition in RA patients and (iii) evaluate the effect on nutrition, physical training, and treatments; that is, corticosteroids and biologic Disease Modifying Anti-Rheumatic Disease (bDMARDs), on BC in RA patients.The primary-source literature for this review was acquired using PubMed, Scopus and Cochrane database searches for articles published up to March 2021. The Medical Subject Headings (MeSH) terms used were ‘Arthritis, Rheumatoid’, ‘body composition’, ‘sarcopenia’, ‘obesity’, ‘cachexia’, ‘Absorptiometry, Photon’ and ‘Electric Impedance’. The titles and abstracts of all articles were reviewed for relevant subjects.Whole-BC measurements were usually performed using dual energy x-ray absorptiometry (DXA) to quantify lean- and fat-mass parameters. In RA patients, lean mass is lower and adiposity is higher than in healthy controls, both in men and women. The prevalence of abnormal BC conditions such as overfat, sarcopenia and sarcopenic obesity is significantly higher in RA patients than in healthy controls; these alterations in BC are observed even at an early stage of the disease. Data on the effect treatments on BC in RA patients are scarce. In the few studies published, (a) creatine supplementation and progressive resistance training induce a slight and temporary increase in lean mass, (b) exposure to corticosteroids induces a gain in fat mass and (c) tumour necrosis factor alpha (TNFα) inhibitors might be associated with a gain in fat mass, while tocilizumab might be associated with a gain in lean mass.The available data clearly demonstrate that alterations in BC occur in RA patients, but data on the effect of treatments, especially bDMARDs, are inconsistent and further studies are needed in this area.
机译:伴随类风湿性关节炎(RA)的身体成分(BC)的改变,越来越感兴趣。本综述的目的是(i)调查如何在RA患者中测量BC,(ii)描述RA患者身体组成的变化和(iii)评估对营养,体育训练和治疗的影响;也就是说,皮质类固醇和改性抗风湿病(BDMARDS)的抗风湿疾病(BDMARDS),在RA患者中。本次审查的主要来源文献是使用PUBMED,SCOPUS和Cochrane数据库搜索获得的,用于2021年3月的文章。医疗所使用的主题标题(网格)术语是“关节炎,类风湿','身体成分','Sarcopenia','肥胖','cachexia','吸解率,photon'和'电阻抗'。所有文章的标题和摘要被审查了相关对象。通常使用双能X射线吸收测定法(DXA)进行何ole-BC测量以定量瘦和脂肪质量参数。在RA患者中,瘦物质较低,肥胖高于男性和女性的健康对照。 RA患者的异常BC条件(如过度,SARCOPENIA和SARCENENIC肥胖)的患病率明显高于健康对照;即使在疾病的早期阶段也观察到BC中的这些改变。 RA患者效应治疗的数据稀缺。在出版的少数研究中,(a)肌酸补充剂和渐进性抗性训练诱导瘦肿块的轻微和暂时的增加,(b)暴露于皮质类固醇,诱导脂肪质量的增益和(c)肿瘤坏死因子α(tnfα)抑制剂可能与脂肪质量的增益有关,而Tocilizuab可能与瘦菌群的增益相关联。可用数据清楚地表明,在RA患者中发生了BC的改变,但有关治疗效果,尤其是BDMARD的数据不一致在该地区需要研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号